- Home
- / Open Bionics
- / Financials
Header placeholder lorem ipsum dolor sit amet, consectetur adipiscing elit.
Open Bionics financials data including stock price, CreditSafe score, balance sheet, and acquistions and subsidiaries.
Total Funding
$6.2 M
CreditSafe Score
?
Score changed on Jul 14, 2025
Premium Content only available in Craft’s Intelligence Portal
View 30+ financial ratio metrics including price-to-earnings ratio, debt-to-assets ratio, gross profit margin, and more.
Financial ratio metrics help evaluate the financial strength of a company, and help raise red flags that can indicate potential risk, fulfillment challenges, or even possible bankruptcy.
Learn moreFinancial Statements
| GBP | FY, 2021 | FY, 2022 | FY, 2023 |
|---|---|---|---|
| Cash | 775.8K | 1.9M | 48.2K |
| Accounts Receivable | 114.1K | 125.2K | 276.3K |
| Prepaid Expenses | 121.7K | 131.5K | 123.2K |
| Inventories | 114.1K | 224.6K | 344.4K |
| Current Assets | 1.5M | 3.3M | 2.7M |
| PP&E | 153.3K | 135.1K | 119.2K |
| Total Assets | 1.7M | 3.5M | 2.8M |
| Accounts Payable | 101.5K | 119.3K | 169.1K |
| Current Liabilities | 836.4K | 851.3K | 700.7K |
| Short-term Debt | 9.1K | 10.4K | 10.1K |
| Long-term Debt | 41.7K | 32.5K | 22.5K |
| Non-Current Liabilities | 41.7K | 32.5K | 22.5K |
| Total Debt | 50.7K | 42.9K | 32.6K |
| Total Liabilities | 878.1K | 883.8K | 723.2K |
| Common Stock | 2.1K | 2.7K | 2.8K |
| Additional Paid-in Capital | 4.8M | 8.0M | 8.8M |
| Retained Earnings | (4.0M) | (5.4M) | (6.7M) |
| Total Equity | 834.2K | 2.6M | 2.1M |
| Debt to Equity Ratio | 0.1 | 0 | 0 |
| Debt to Assets Ratio | 0 | 0 | 0 |
| Financial Leverage | 2.1 | 1.3 | 1.3 |
Acquisitions & Subsidiaries
| Company name | Date | Deal size |
|---|---|---|
| Lorem | Dec 23, 2021 | $40.0M |
| Ipsum | Jan 18, 2022 | $30.0M |
| Lorem Ipsum | Feb 18, 2022 | $25.0M |
| Dolor | Oct 21, 2021 | $60.0M |
Premium Content only available in Craft’s Intelligence Portal View acquisitions and subsidiaries by company, date, and deal size. Understanding this data enables better supplier & customer negotiations and helps identify potential opportunities or market risks for your firm. Learn more |